These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 26889975)
1. Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve. Koukourakis MI; Mitrakas AG; Giatromanolaki A Br J Cancer; 2016 Mar; 114(5):485-96. PubMed ID: 26889975 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era. Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233 [TBL] [Abstract][Full Text] [Related]
3. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme. Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509 [TBL] [Abstract][Full Text] [Related]
4. An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective. Pawlowska E; Szczepanska J; Szatkowska M; Blasiak J Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562589 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines. Oancea-Castillo LR; Klein C; Abdollahi A; Weber KJ; Régnier-Vigouroux A; Dokic I Cancer Biol Ther; 2017 Jun; 18(6):400-406. PubMed ID: 28494176 [TBL] [Abstract][Full Text] [Related]
6. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Grossman SA; Ye X; Piantadosi S; Desideri S; Nabors LB; Rosenfeld M; Fisher J; Clin Cancer Res; 2010 Apr; 16(8):2443-9. PubMed ID: 20371685 [TBL] [Abstract][Full Text] [Related]
7. The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma. Park CK; Lee SH; Kim TM; Choi SH; Park SH; Heo DS; Kim IH; Jung HW J Neurooncol; 2013 Apr; 112(2):277-83. PubMed ID: 23377829 [TBL] [Abstract][Full Text] [Related]
8. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244 [TBL] [Abstract][Full Text] [Related]
10. DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. Galbán S; Lemasson B; Williams TM; Li F; Heist KA; Johnson TD; Leopold JS; Chenevert TL; Lawrence TS; Rehemtulla A; Mikkelsen T; Holland EC; Galbán CJ; Ross BD PLoS One; 2012; 7(4):e35857. PubMed ID: 22536446 [TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme. Abrey LE Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881 [No Abstract] [Full Text] [Related]
12. Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component. O'Leary B; Mandeville HC; Fersht N; Solda F; Mycroft J; Zacharoulis S; Vaidya S; Saran F J Neurooncol; 2016 Apr; 127(2):295-302. PubMed ID: 26842817 [TBL] [Abstract][Full Text] [Related]
13. Potential usefulness of radiosensitizers in glioblastoma. Harasaki Y; Waziri A Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655 [TBL] [Abstract][Full Text] [Related]
14. Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme. Ammirati M; Chotai S; Newton H; Lamki T; Wei L; Grecula J J Clin Neurosci; 2014 Apr; 21(4):633-7. PubMed ID: 24380758 [TBL] [Abstract][Full Text] [Related]
15. Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma. Yoon SM; Kim JH; Kim SJ; Khang SK; Shin SS; Cho YH; Jwa E; Park JH; Ahn SD Tumori; 2013; 99(4):480-7. PubMed ID: 24326836 [TBL] [Abstract][Full Text] [Related]
16. Radiation and concomitant chemotherapy for patients with glioblastoma multiforme. Villà S; Balañà C; Comas S Chin J Cancer; 2014 Jan; 33(1):25-31. PubMed ID: 24325790 [TBL] [Abstract][Full Text] [Related]
17. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report. Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499 [TBL] [Abstract][Full Text] [Related]
18. Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype. Fouse SD; Nakamura JL; James CD; Chang S; Costello JF Neuro Oncol; 2014 Mar; 16(3):361-71. PubMed ID: 24311636 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Niyazi M; Schwarz SB; Suchorska B; Belka C Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634 [TBL] [Abstract][Full Text] [Related]
20. Current and Future Drug Treatments for Glioblastomas. Ohba S; Hirose Y Curr Med Chem; 2016; 23(38):4309-4316. PubMed ID: 27758718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]